AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Covid - Exploration (Accueil)

Index « AbsEn.i » - entrée « therapeutic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
theory < therapeutic < therapeutics  Facettes :

List of bibliographic references indexed by therapeutic

Number of relevant bibliographic references: 76.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000035 (2020) B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine][Pharmacotherapeutics for the New Coronavirus Pneumonia].
000041 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000049 (2020) B L Liu [République populaire de Chine] ; F. Ma ; J N Wang ; Y. Fan ; H N Mo ; B H Xu[Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel coronavirus disease].
000068 (2020) L. Yang [République populaire de Chine] ; H Y Xu [République populaire de Chine] ; Y. Wang [République populaire de Chine][Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].
000121 (2020) Yaqing Fang [République populaire de Chine] ; Yiting Nie [République populaire de Chine] ; Marshare Penny [États-Unis]Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
000132 (2020) Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000148 (2020) Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine]The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.
000191 (2020) Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000206 (2020) Jaffar A. Al-Tawfiq [États-Unis] ; Ali H. Al-Homoud [Arabie saoudite] ; Ziad A. Memish [États-Unis]Remdesivir as a possible therapeutic option for the COVID-19.
000243 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000250 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000325 (2020) Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000470 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000476 (2020) Li Ni [République populaire de Chine] ; Ling Zhou [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Jianping Zhao [République populaire de Chine] ; Dao Wen Wang [République populaire de Chine]Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan.
000506 (2020) Sheng-Qun Deng [République populaire de Chine] ; Hong-Juan Peng [République populaire de Chine]Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.
000521 (2020) Silvia Angeletti [Italie] ; Domenico Benvenuto [Italie] ; Martina Bianchi [Italie] ; Marta Giovanetti [Brésil] ; Stefano Pascarella [Italie] ; Massimo Ciccozzi [Italie]COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis.
000540 (2020) Kam Wa Chan [Hong Kong] ; Vivian Taam Wong [Hong Kong] ; Sydney Chi Wai Tang [Hong Kong]COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.
000562 (2020) Didier Raoult [France] ; Po-Ren Hsueh [Taïwan] ; Stefania Stefani [Italie] ; Jean-Marc Rolain [France]COVID-19 Therapeutic and Prevention.
000569 (2020) Jimin Xu ; Pei-Yong Shi ; Hongmin Li [États-Unis] ; Jia ZhouBroad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
000615 (2020) Tommaso Lupia [Italie] ; Silvia Scabini [Italie] ; Simone Mornese Pinna [Italie] ; Giovanni Di Perri [Italie] ; Francesco Giuseppe De Rosa [Italie] ; Silvia Corcione [Italie]2019-novel coronavirus outbreak: A new challenge.
000637 (2019) Jae C. ChangSepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapeutic
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021